Advertisement
Screener

RIGEL PHARMACEUTICALS, INC. (RIGL) Material Contracts, 2009

RIGEL PHARMACEUTICALS, INC. Material Contracts

Every material contract the company filed as Exhibit 10 (executive pay plans, credit agreements, supplier and indemnity agreements), newest first, with the filing's own description.

  • 2009-11-03: Form 10-Q; Exhibit 10.7A; Description Amendment No. Two to Build-to-Suit Lease between the Company and Slough BTC, LLC, dated January 31, 2005..
  • 2009-11-03: Form 10-Q; Exhibit 10.7B; Description Amendment No. Three to Build-to-Suit Lease between the Company and Slough BTC, LLC dated July 24, 2006..
  • 2009-08-04: Form 10-Q; Exhibit 10.2; Description Rigel Pharmaceuticals, Inc. Non-Employee Directors’ Stock Option Plan, as amended..
  • 2009-08-04: Form 10-Q; Exhibit 10.1; Description Rigel Pharmaceuticals, Inc. 2000 Equity Incentive Plan, as amended..
FiledFormExhibitDescription
2009-11-0310-Q10.7AAmendment No. Two to Build-to-Suit Lease between the Company and Slough BTC, LLC, dated January 31, 2005.
2009-11-0310-Q10.7BAmendment No. Three to Build-to-Suit Lease between the Company and Slough BTC, LLC dated July 24, 2006.
2009-08-0410-Q10.2Rigel Pharmaceuticals, Inc. Non-Employee Directors’ Stock Option Plan, as amended.
2009-08-0410-Q10.1Rigel Pharmaceuticals, Inc. 2000 Equity Incentive Plan, as amended.
2009-05-0510-Q10.1Amendment No. Four to the Build-to-Suit Lease between Rigel and HCP BTC, LLC dated February 1, 2009.
2009-04-018-K10.282009 Cash Incentive Plan.
2009-02-2710-K10.262000 Employee Stock Purchase Plan, as amended.
2009-02-2710-K10.25Change of Control Severance Plan.
2009-02-2710-K10.24Amended and Restated Employment Agreement between Rigel and Donald Payan, dated November 13, 2008.

Similar stocks

Stock NameCountryMarket CapPE Ratio
Apnimed, Inc. (APMD)United States$0.899B
Theravance Biopharma, Inc. (TBPH)$0.885B16.40
Cryoport, Inc. (CYRX)United States$0.881B-21.29
ARDELYX, INC. (ARDX)United States$0.857B-22.86
Jade Biosciences, Inc. (JBIO)United States$0.936B-9.21
Avalo Therapeutics, Inc. (AVTX)United States$0.842B-9.74
Immix Biopharma, Inc. (IMMX)United States$0.837B-18.44
Obsidian Therapeutics, Inc. (OBX)United States$0.829B
LEXICON PHARMACEUTICALS, INC. (LXRX)United States$0.823B-17.48
Arbutus Biopharma Corp (ABUS)$0.965B6.19